| 111 wileyonlinelibrary.com/journal/jch 1 | BACKG ROU N D Cardiovascular diseases (CVD) are responsible for 18 million deaths annually-a third of all deaths worldwide. 1 Over three-quarters of CVD morbidity occurs in low-income and middle-income countries (LMICs), where it is more likely to strike prematurely (under the age of 70). 2 CVD is largely preventable through population-wide approaches to reduce harmful behaviors such as smoking, physical inactivity, high dietary intake of salt and trans-fatty acids, and patient-centered approaches to address CVD risk factors such as hypertension, diabetes, and hyperlipidemia. 1-3 Recognizing the rising significance of CVD globally, all 194 WHO member states have established 2020 targets of reducing the risk of premature CVD death by 25%, reducing the prevalence of high blood pressure by 25%, and increasing drug treatment for the prevention of CVD by 50%. 2 The Global Hearts Initiative (GHI) provides a comprehensive set of strategies for improving cardiovascular health globally. A principal GHI component is HEARTS, a technical package of strategies Abstract
The HEARTS technical package, a part of the Global Hearts Initiative to improve cardiovascular health globally, is a strategic approach for cardiovascular disease prevention and control at the primary care level. To support the evaluation of costs associated with HEARTS program components, a costing tool was developed to evaluate the incremental cost of program implementation. This report documents an application of the HEARTS costing tool during a costing workshop prior to the initiation of a HEARTS pilot program in Thailand's Phothong District, 2019-2020. During the workshop, a mock exercise was conducted to estimate the expected costs of the pilot study. The workshop application of the tool underscored its applicability to the HEARTS program planning process by identifying cost drivers associated with individual program elements. It further illustrated that by supporting disaggregation of costs into fixed and variable categories, the tool can inform the scalability of pilot projects to larger populations. Lessons learned during the initial development and application of the costing tool can inform future HEARTS evaluation efforts.
for CVD prevention and management at the primary care level. 4, 5 HEARTS focuses on CVD reduction through lifestyle counseling, standardized protocols for medication treatment, improved access to medication, and strengthened health care efficiencies through monitoring, team-based care, and CVD risk assessment. Given the key role of hypertension in all-cause and CVD mortality, 6 combined with high levels of uncontrolled hypertension in LMICs, 7, 8 HEARTS places a strong emphasis on improving health outcomes at the population level through streamlining service delivery in primary care.
Incorporating HEARTS program components in country health systems depends on the availability of information on expected health outcomes and expected costs associated with implementation. To support the evaluation of HEARTS program costs, a cost-assessment instrument was developed as part of program planning. The HEARTS costing tool is an Excel-based platform for collecting and summarizing the incremental costs associated with HEARTS implementation. The tool can facilitate program development by informing budgeting needs for program rollout and scale-up.
This report describes the HEARTS costing tool and its relevance to budget planning and evaluation by documenting an application of the tool at the initiation of a HEARTS pilot program in Thailand.
Lessons learned and gaps identified during the initial development and application of the costing tool can inform improvements in future HEARTS evaluation efforts.
| THE HE ARTS COS TING TOOL

| Context
The HEARTS technical package provides a framework for CVD prevention and management with six practical, step-by-step modules. 5 HEARTS modules are based on the following themes: H-Healthy
Lifestyle, E-Evidence-Based Treatment Protocols, A-Access to Essential Medicines and Technology, R-Risk-Based Management, T-Team Care and Task Sharing, and S-Systems for Monitoring. A robust monitoring and evaluation framework to track process indicators and health outcomes is an integral part of the package. HEARTS is implemented at primary health facilities that typically handle risk screening, assessment, management, and referral of high-risk patients to district hospitals and may involve community outreach to promote health education and preliminary screening. Modules can be adopted selectively or adapted to the local context based on the availability of personnel, medicines, and technology at primary health care centers. 5 When considering selective implementation or program expansion, country decision-makers might examine and compare the costs of implementing individual HEARTS components, taking into account resource availability and sustainability. To this end, a comprehensive yet simple-to-use costing tool provides necessary program-specific information.
| Costing tool overview
The HEARTS costing tool uses an activity-based costing approach, where a cost is derived for every activity conducted as part of the program. It assumes a one-year time horizon and is organized according to the six HEARTS elements. It captures the incremental cost of implementation of each HEARTS element thereby highlighting the additional resources needed to rollout the program over the specified time period. The development of the tool entailed an iterative process of identification of the cost components through expert and stakeholder consultations and reviews, compliance with the underpinnings of cost theories and existing global cost frameworks (eg, WHO-PEN, WHO-CHOICE/OneHealth Tool). 9, 10 An overview of the tool is presented in Table 1 .
In addition to supporting program planning and evaluation within individual countries, a contribution of employing the HEARTS
TA B L E 1 Overview of the HEARTS costing tool
Who?
The HEARTS costing tool is an Excel-based instrument to collect, track, and evaluate the incremental cost of participating in the HEARTS program.
What?
The costing tool will provide information that can be used to inform national stakeholders about budget needs for HEARTS service delivery. The implementing health facility will be provided with a User's Guide to provide instructions, facilitate data collection, and guide the development of a set of standardized reports.
How?
The tool is organized to track costs by HEARTS elements: Healthy 
| Costing tool structure
| Title page and guide
The "Title page" worksheet tab contains the 
| Initialize page
In the "initialize" worksheet tab, the user selects a country from a list of pre-determined countries. Upon country selection, the costing tool calculator becomes prepopulated with default values of costs and other inputs obtained from the WHO-PEN tool. 9 The user can also supply input values specific to their own district if they are available. Input cells in this costing tool are color-coded in either blue or green, where the user can enter data into blue cells; remaining cells would be populated automatically using default values. Green cells are not to be altered as these are generated automatically and contain formulas.
| H: Healthy lifestyles
The 
| E: Evidence-based treatment protocols
| A: Access to essential medicines and technologies
The HEARTS package promotes the use of simplified treatment protocols with a defined list of core medicines and technology for managing key CVD risk factors and facilitating procurement and distribution mechanisms. This worksheet tab is prepopulated with a list of medicines, diagnostic technologies, tools and protocol logistics (eg, prediction charts, clinical record, and referral criteria), and associated staffing cost (eg, laboratory technician and pharmacist). sharing. If the time to conduct tasks by physicians decreased as other providers take up task sharing, it is possible to observe cost savings.
| R: Risk-based management
| T: Team care and task sharing
| S: Systems for monitoring
In the HEARTS technical package, systems for registration and patient and cohort monitoring will be aligned with ongoing initiatives to standardize health management information systems in primary 
| Administrative Costs
This worksheet tab is used to keep track of miscellaneous implementation costs. 
| Reporting
| Hypertension prevention (HTN-P) and hypertension treatment (HTN-T)
In some instances, countries may limit the scope of the CVD program to hypertension management only, using hypertension as an entry point to broader CVD interventions. Two additional worksheet tabs are available to track the costs of activities specific to hypertension prevention and treatment, such as the cost of medicines, durable equipment, and personnel.
| HE ARTS COS TING TOOL : A C A S E S TUDY APPLI C ATI ON IN THAIL AND
| Project description
The The total cost estimate generated during the workshop was close to the ex-ante stipulated program budget of $33 000 that was sent by the implementing agency to the funding agency before the workshop. Specifically, the pilot program plan by the Thailand Bureau of NCDs indicated that 58% of the ex-ante budget was attributed to personnel cost, 20% to equipment, supplies, and travel, and 22% to other costs. However, these ex-ante budget allocations were not further disaggregated by program activity and were not classified as fixed or variable, limiting the comparability of the ex-ante budget to the costing tool estimation. Information on program costs is essential not only to assess program efficiency, make cost projections, and inform budgeting and procurement but also to help national managers to effectively plan and coordinate future program resources. 11 It can help to identify areas where economies of scale can support program expansion through spreading out fixed costs over larger patient populations. When cost data collection over time is aligned with the collection of monitoring and evaluation indicators that track process and health outcomes, cost-effectiveness evaluations can be conducted to describe program performance.
| Costing tool workshop
| CON CLUS ION
To accommodate the country needs for forecasting HEARTS costs that have not yet been incurred, a prospective version of the HEARTS costing tool can be used. The prospective version of the tool projects costs under different implementation scenarios in order to support program uptake that is optimal for each individual county context. During the planning stages of HEARTS implementation, choice of treatment protocols and counseling interventions might be dependent on expected costs. By estimating future expenditures, the costing tool can help to guide program implementation from a practical angle by establishing budget needs, informing program evaluation, and supporting optimal health policy action.
CO N FLI C T O F I NTE R E S T
The authors declare no conflict of interest. 
AUTH O R CO NTR I B UTI
D I SCL A I M ER
The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.
O RCI D
Muhammad Jami Husain https://orcid. org/0000-0001-6049-0505
R E FE R E N C E S
